Director at Modular Medical (NASDAQ: MODD) receives option grant for 250 shares

Rhea-AI Filing Summary

Modular Medical, Inc. director Jeff D. Goldberg received an option grant to purchase 250 shares of common stock. The option was awarded on June 30, 2026 under the company’s Outside Director Compensation Plan, with an exercise price of $4.88 per share, and was fully vested and exercisable on the grant date. The option for 250 underlying common shares expires on June 30, 2036, and represents his reported beneficial ownership of this class of derivative security following the transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Goldberg Jeff D

Role null

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock	250	$0.00	--

Holdings After Transaction: Option to purchase common stock — 250 shares (Direct, null)

Footnotes (1)

1. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Key Figures

Option grant size: 250 options Exercise price: $4.88 per share Expiration date: June 30, 2036 +3 more

6 metrics

Option grant size 250 options Options to purchase 250 shares of common stock granted June 30, 2026

Exercise price $4.88 per share Conversion or exercise price for the option award

Expiration date June 30, 2036 Option to purchase common stock expires on this date

Shares underlying option 250 shares Underlying common stock covered by the derivative security

Total derivative holdings after grant 250 options Total beneficial ownership of this class of derivative security

Vesting status Fully vested at grant Option fully vested and exercisable on June 30, 2026

Key Terms

Outside Director Compensation Plan, beneficial ownership, derivative security, exercise price

4 terms

Outside Director Compensation Plan financial

"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan"

beneficial ownership financial

"column 9 reports only total beneficial ownership of the "class" of derivative security"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

derivative security financial

"total beneficial ownership of the "class" of derivative security reported in column 1"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

exercise price financial

"Options that have different exercise prices or vesting terms are not considered to be of the same "class.""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:33 PM Accepted by SEC EDGAR 07/02/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldberg Jeff D

(Last) (First) (Middle)

C/O MODULAR MEDICAL, INC.

10740 THORNMINT ROAD

(Street)

SAN DIEGO CALIFORNIA 92127

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock(1)	$4.88	06/30/2026		A		250		06/30/2026	06/30/2036	Common Stock	250	(1)	250(2)	D

Explanation of Responses:

1. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

	/s/ James Sullivan, Attorney in Fact for Jeff D. Goldberg	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Modular Medical (MODD) report for Jeff D. Goldberg?

Modular Medical reported that director Jeff D. Goldberg received an option grant for 250 shares of common stock. The derivative award was recorded on June 30, 2026 and reflects compensation rather than an open-market stock purchase or sale.

How many Modular Medical (MODD) shares are covered by Jeff D. Goldberg’s new option?

The option grant covers 250 underlying shares of Modular Medical common stock. This relatively small award represents his beneficial ownership of this specific class of derivative security as reported in the filing after the June 30, 2026 grant.

What is the exercise price and term of Jeff D. Goldberg’s Modular Medical (MODD) option?

The option has an exercise price of $4.88 per share and expires on June 30, 2036. This gives the director the right to buy 250 shares at $4.88 any time before expiration, subject to plan terms.

When did Jeff D. Goldberg’s Modular Medical (MODD) option vest?

The company states the option was fully vested and exercisable on the June 30, 2026 grant date. This means Goldberg did not need to wait through a vesting schedule before being allowed to exercise the 250-share option.

Is Jeff D. Goldberg’s Modular Medical (MODD) option grant an open-market purchase?

No, the grant is compensation, not an open-market purchase. It was awarded under Modular Medical’s Outside Director Compensation Plan, with a reported exercise price of $4.88 per share for 250 underlying common shares.